NCT07192263View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

September 30, 2027

Conditions
Obesity &Amp; Overweight
Interventions
DRUG

IN-B00009

Test drug

DRUG

Placebo

Placebo drug

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT07192263 - Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus | Biotech Hunter | Biotech Hunter